62
Participants
Start Date
October 17, 2022
Primary Completion Date
March 20, 2023
Study Completion Date
March 20, 2023
B. adolescentis Bif-038
B. adolescentis Bif-038 (probiotic capsule) delivered orally once daily at a minimum of 5 billion CFU/day
Lacticaseibacillus rhamnosus, LGG® and Bifidobacterium, BB-12®
Lacticaseibacillus rhamnosus, LGG® and Bifidobacterium, BB-12® (probiotic capsule) delivered orally once daily at a minimum of 1 billion CFU/day
Placebo
Placebo capsule delivered orally once daily
Clinical Research Australia, Duncraig
Chr Hansen
INDUSTRY